Study: Surgical delay associated with increased risk in some gastrointestinal malignancies

Boston, Mass. – Early in the COVID-19 pandemic, widespread cancellations of electively-scheduled or “non-emergency” operations were implemented to free up hospital beds and conserve protective equipment for health care workers. For some conditions, including cancer, timely surgery is critical for patients’ survival. In a new study published in the Journal of Gastrointestinal Surgery, a team…

Details

Diagnosis to therapy: The future of image-guided patient management

WHAT: The Society of Nuclear Medicine and Molecular Imaging 2020 Virtual Annual Meeting Novel research on new and better ways to diagnose and treat cancers, inflammation, arthritis, chronic pain, stroke, brain disease, and more The SNMMI Virtual Annual Meeting will convene more than 6,000 attendees (physicians, scientists, technologists and exhibitors) from around the globe to…

Details

TARA biosystems demonstrates in vitro cardiac biology model mimics human drug response

NEW YORK, July 7, 2020–TARA Biosystems today reported study results demonstrating the ability of TARA’s in vitro human cardiac models to reproduce drug responses similar to those observed in humans. Appearing in the Journal of Pharmacological and Toxicological Methods, these findings further support the use of TARA’s in vitro human cardiac models as a robust,…

Details

Medicare’s race, ethnic data often undercounts minority populations, study finds

The information critical to a nationwide priority of reducing health care disparities among minorities is incomplete and inaccurate, according to a new Rutgers study. Published in Medical Care Research & Review and Medical Care, the study compared Medicare beneficiaries’ race and ethnicity data from the two most widely-used administrative data sources, to data sources that…

Details

CU Healthcare Innovation Fund closes with $50 million in committed capital

AURORA, CO (July 7, 2020)–The CU Healthcare Innovation Fund announced today that it has secured its maximum targeted committed capital of $50 million. The fund is affiliated with and located on the University of Colorado Anschutz Medical Campus near Denver, Colorado. The limited partners include, among others, the University of Colorado, UCHealth, Children’s Hospital Colorado…

Details